about
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery,...
Read More
3.83
0.08
(2.13%)
298.0K
XNAS Volume
XNAS 11 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
NervGen Pharma Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..